Sambrinvest

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

AdipoPharma focuses on understanding and harnessing the role of adipocyte cells in treating insulin resistance and type 2 diabetes. The company's platform involves detailed genetic investigation and peptide-based drug development to improve insulin sensitivity, reduce liver fibrosis, and enhance overall metabolic health.

AbolerIS Pharma is a biotechnology company based in Nantes, France, specializing in the development of immune-modulators aimed at treating transplant rejection, graft-versus-host disease, and autoimmune diseases. Incorporated in 2019, the company offers innovative products such as Anti-CD45RC, a monoclonal antibody designed to deplete effector T cells, and IL-34, a cytokine that promotes the induction of tolerogenic macrophages and regulatory T cells. AbolerIS Pharma employs a unique therapeutic approach that fosters immune tolerance while preserving beneficial immune responses in the context of inflammatory, autoimmune, and degenerative diseases. This strategy allows the company to focus on advancing novel drugs to address significant unmet medical needs in these therapeutic areas.

Cikisi specializes in Web Intelligence, helping businesses harness relevant web information for growth. It develops Cikisi WMT, a software solution that collects, searches, and filters web data.

Santero Therapeutics specializes in developing novel antimicrobial medications that target drug-resistant pathogens. Its focus is on creating treatments with fresh modes of action to combat antibiotic resistance.

Sunrise is a medical technology company focused on improving the diagnosis and management of sleep disorders, particularly sleep apnea, which affects nearly one billion people worldwide. The company has developed a 3-gram sensor that allows for rapid and accurate at-home diagnosis of sleep conditions, utilizing trigeminal drive analysis to detect respiratory events. This innovative device is clinically validated for use in both adults and children and provides a cost-effective alternative to traditional in-lab sleep studies. Users receive a single-use sensor delivered to their home, which connects easily to their phone for seamless operation. Following the test, Sunrise facilitates consultations with certified sleep doctors or connections to local sleep centers, addressing a critical need in a healthcare landscape where 80% of sleep apnea cases remain undiagnosed.

Exthand is a developer of open banking solutions that provides clients with access to a single API connecting to the APIs of 95% of banks in Europe, the UK, and Israel. This connectivity enables instant account-to-account payments and facilitates the retrieval of data from bank accounts. Exthand's offerings can enhance various financial processes, including personal finance management, credit scoring, and cash flow management. By leveraging these capabilities, businesses can benefit from faster and more cost-effective payment solutions while streamlining their accountancy and financial operations.

Aerospacelab is a Belgian company founded in 2017 that designs, builds, and operates small satellites equipped with high‑resolution optical sensors. Its platform captures multiple images of the same area, enabling frequent monitoring of land, infrastructure, and environmental changes. The company integrates artificial intelligence and machine learning to automate tasks such as surveying, data processing, and analysis, allowing clients to quickly interpret large volumes of imagery. Headquartered near Brussels, Aerospacelab serves customers in agriculture, forestry, urban planning, and disaster response, providing actionable insights from satellite data.

Cake App mission is to become the leading software technology provider that analyzes financial data to help people better understand, control and improve their finances, supported by a business model that shares our revenue with users.

HeartKinetics specializes in AI-driven solutions for rapid and accurate detection of heart failure and cardio-toxicity. Utilizing a network of nine AI models trained on thousands of patients from Mayo Clinic, it assesses cardiac mechanical and electrical functions within minutes, predicting ventricular ejection dysfunction and main arrhythmias. The company's lightweight solution, based on motion sensors embedded in Holter ECG patches, aims to enable early detection of cardiac complications for timely therapeutic decisions.

PDC*line Pharma is a French-Belgium clinical-stage biotech company developing active immunotherapies for cancer using its proprietary Plasmacytoid Dendritic Cell line, PDC*line. These therapies aim to stimulate potent and scalable antitumor immune responses.

HireRing is an on-demand staffing platform that connects employers with specialized recruitment agencies tailored to their specific hiring needs. By allowing employers to submit vacancy requests and set upfront hiring fees, the platform streamlines the recruitment process. This efficiency enables recruitment agencies to quickly identify and select suitable business opportunities, ensuring that employers receive quality service from qualified professionals. Through its marketplace model, HireRing facilitates a seamless interaction between employers and recruiters, enhancing the overall hiring experience.

EsoBiotec is a Belgian biotechnology company dedicated to discovering novel cancer therapies. Its mission is to empower the human body to fight cancer by developing 'in vivo' cell engineering treatments, making cancer therapies more accessible and affordable.

Sortlist is a platform designed to simplify the process of finding suitable marketing and communication agencies for businesses. It offers an online multi-criteria searching tool connected to professional networks and peer recommendations, enabling companies to swiftly identify potential partners that align with their specific needs.

Amyl Therapeutics is a preclinical biotech company developing therapeutics targeting various amyloid fibrils, including those implicated in systemic amyloidosis and neurodegenerative diseases like Alzheimer's and Parkinson's.

Shyfter is a comprehensive scheduling platform that optimizes workforce management for various industries. It automates routine tasks such as creating employee schedules, real-time time tracking, absence management, and communication channels. The platform's AI-driven productivity calculations ensure optimal staffing levels while its advanced analytics provide valuable insights into workforce trends.

ExeVir Bio BV is a Belgian biotechnology company founded in 2020 and headquartered in Zwijnaarde. The company specializes in developing single-domain antibody-based therapies aimed at preventing viral infections. Utilizing a llama-derived antibody technology platform, ExeVir Bio focuses on creating robust antiviral treatments, particularly targeting coronaviruses. One of its key products, VHH72-FC, binds to a conserved region of the SARS-CoV-2 spike protein, which is crucial for the virus's entry into human cells. The company has established a rapid response platform for antivirals, allowing for a quick adaptation to emerging health threats through a streamlined process for generating drug candidates. Their protein-based therapeutics are designed to be stable, cost-effective, and accessible on a global scale, addressing significant public health challenges posed by viral infections.

Founded by experts in DNA sequencing and diagnostic analyses in oncology, OncoDNA offers precision medicine solutions for cancer treatment. It provides clinical guidance for late-stage patients, supports research, and aids drug development.

PDC*line Pharma is a French-Belgium clinical-stage biotech company developing active immunotherapies for cancer using its proprietary Plasmacytoid Dendritic Cell line, PDC*line. These therapies aim to stimulate potent and scalable antitumor immune responses.

Utopix Pictures SA is a Belgium-based company founded in 2015, specializing in connecting clients with professionals in the photography, film, and image industries. Operating from Mont-Saint-Guibert, Utopix Pictures provides a platform designed to streamline the process of finding the right photographer or videographer for various business projects. The company emphasizes the importance of visual content in effectively conveying ideas and aims to facilitate the quick and easy selection of skilled professionals who can turn concepts into compelling images.

Cognivia is a company that focuses on developing analytical tools aimed at optimizing and accelerating the clinical development of new medicines. Its innovative tools employ predictive techniques to enhance the clinical evaluation of drugs and other therapeutics. By addressing and mitigating the variability in clinical trial data, Cognivia enables its clients to identify and manage critical sources of variability, ultimately improving the efficiency and effectiveness of clinical trials.

Smartbeam is a construction-tech platform focused on enhancing collaboration among stakeholders in real estate construction projects while improving financial oversight on construction sites. The company offers features such as automated data collection and analysis, along with real-time budget tracking, which collectively streamline workflows from the pre-construction phase through to completion. By providing robust budget management tools, Smartbeam aims to increase project efficiency, reduce rework, and boost productivity. The platform is designed to enhance the reliability of budgets and minimize financial risks, ultimately supporting construction professionals in managing their projects more effectively.

Djengo is a technology company specializing in smart parking management and green mobility solutions for businesses. Its flagship product, Commuty, is designed to optimize corporate parking, mobility, and office space through an automated reservation system. Djengo's services cater to a diverse range of users, including visitors, individuals with reduced mobility, carpoolers, cyclists, and electric vehicle owners. In addition to parking management, Djengo also offers a ridesharing platform that facilitates peer-to-peer ridesharing and carpooling for home-to-work commuting. By integrating these services, Djengo aims to enhance the efficiency of urban mobility and promote sustainable transportation solutions for companies.

Founded in 2014, Commuty is a Belgian company that develops web and mobile applications for parking and mobility management. Its platform enables smart parking spot allocation and booking based on company policies, promotes bicycle sharing among employees, and facilitates carpooling arrangements, helping businesses save money while increasing flexibility.

Sortlist is a platform designed to simplify the process of finding suitable marketing and communication agencies for businesses. It offers an online multi-criteria searching tool connected to professional networks and peer recommendations, enabling companies to swiftly identify potential partners that align with their specific needs.

Minoryx Therapeutics is a biotechnology company based in Mataro, Spain, founded in 2011. The company specializes in discovering and developing innovative treatments for life-threatening rare diseases, with a particular focus on pediatric neurometabolic conditions of genetic origin. Minoryx is known for its development of pharmacological chaperones, a new generation of small molecule drugs designed to restore protein functionality, thereby addressing unmet medical needs in genetic diseases that severely affect the central nervous system. Additionally, Minoryx engages in repositioning-based projects to explore alternative therapeutic options for these challenging conditions.

ChromaCure is a biotechnology company focused on developing innovative cancer therapies. The company specializes in discovering first-in-class small molecule therapeutics that address unmet needs in oncology. ChromaCure's primary goal is to identify potential new drug candidates that selectively and potently inhibit cancer targets, offering novel treatment options for various forms of cancer. These therapies are designed to be used either as monotherapy or in combination with existing treatments such as immunotherapy or chemotherapy, aiming to provide more effective solutions for cancer patients.

Ncardia develops predictive human cellular assay systems based on human induced pluripotent stem cells (hiPSCs) to support safety and efficacy testing of drug candidates and enhance cardiovascular and neural drug screening. By producing hiPSC-derived models that reflect human disease biology, the company helps researchers and drug developers better predict human responses, streamline preclinical evaluation, and accelerate the discovery and development of new therapies.

Ncardia develops predictive human cellular assay systems based on human induced pluripotent stem cells (hiPSCs) to support safety and efficacy testing of drug candidates and enhance cardiovascular and neural drug screening. By producing hiPSC-derived models that reflect human disease biology, the company helps researchers and drug developers better predict human responses, streamline preclinical evaluation, and accelerate the discovery and development of new therapies.

Opinum is a Belgian company based in Braine l'Alleud, specializing in hardware technologies and digital solutions for the energy and environmental sectors. It has developed the Opinum Data Hub, a platform designed to facilitate the digital transformation of organizations involved in energy management. The platform encompasses the entire data management value chain, allowing users to navigate complex data while focusing on their core competencies. Opinum's software enables businesses to analyze and visualize energy and environmental data, effectively tracking and regulating the consumption of resources such as gas, water, and electricity. Its primary clients include large private and public service companies, energy suppliers, and energy services companies (ESCOs).

X4C specializes in developing advanced monolayer chemical coating technology for a variety of life science applications. The company creates molecular coatings tailored for in vitro diagnostics, medical devices, electronics, and optics. X4C's innovative platform employs a unique approach to surface coating that allows for the precise grafting of robust organic monolayers. This technology enables healthcare professionals to impart specific functionalities to substrates while maintaining their inherent properties. Additionally, X4C offers a range of products, including nanoparticles and calixarenes, along with customized services to meet the diverse needs of its clients in the life sciences sector.

Opinum is a Belgian company based in Braine l'Alleud, specializing in hardware technologies and digital solutions for the energy and environmental sectors. It has developed the Opinum Data Hub, a platform designed to facilitate the digital transformation of organizations involved in energy management. The platform encompasses the entire data management value chain, allowing users to navigate complex data while focusing on their core competencies. Opinum's software enables businesses to analyze and visualize energy and environmental data, effectively tracking and regulating the consumption of resources such as gas, water, and electricity. Its primary clients include large private and public service companies, energy suppliers, and energy services companies (ESCOs).

Opinum is a Belgian company based in Braine l'Alleud, specializing in hardware technologies and digital solutions for the energy and environmental sectors. It has developed the Opinum Data Hub, a platform designed to facilitate the digital transformation of organizations involved in energy management. The platform encompasses the entire data management value chain, allowing users to navigate complex data while focusing on their core competencies. Opinum's software enables businesses to analyze and visualize energy and environmental data, effectively tracking and regulating the consumption of resources such as gas, water, and electricity. Its primary clients include large private and public service companies, energy suppliers, and energy services companies (ESCOs).

Calyos is a company specializing in thermal regulation systems, focusing on advanced loop heat pipe cooling products. Originating from the space industry, Calyos leverages its expertise and scalable manufacturing capabilities alongside patented technologies to provide innovative cooling solutions. The company's systems utilize a dielectric fluid that absorbs heat and vaporizes at low temperatures, allowing clients to effectively manage heat in high-performance electronics across diverse applications, including servers, renewable energy systems, and telecommunications equipment. By enabling designers to create products without thermal limitations, Calyos aims to enhance the competitiveness of its clients' offerings in the market.